CC-99677, a novel, oral, selective covalent MK2 inhibitor, sustainably reduces pro-inflammatory cytokine production

BACKGROUND: Mitogen-activated protein kinase (MAPK)-activated protein kinase-2 (MK2) is activated downstream of p38 MAPK and regulates stability of mRNAs encoding inflammatory cytokines. CC-99677 is a novel, irreversible, covalent MK2 inhibitor under development for the treatment of ankylosing spond...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaur, Rajula, Mensah, Kofi A., Stricker, Jason, Adams, Mary, Parton, Anastasia, Cedzik, Dorota, Connarn, Jamie, Thomas, Michael, Horan, Gerald, Schafer, Peter, Mair, Stuart, Palmisano, Maria, Ramírez-Valle, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386913/
https://www.ncbi.nlm.nih.gov/pubmed/35982464
http://dx.doi.org/10.1186/s13075-022-02850-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386913/
https://www.ncbi.nlm.nih.gov/pubmed/35982464
http://dx.doi.org/10.1186/s13075-022-02850-6

Ejemplares similares